Education and Supportive Partners Improving Self-Care (ENSPIRE)
NCT ID: NCT00166049
Last Updated: 2015-11-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
170 participants
INTERVENTIONAL
2005-04-30
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Family Intervention for Improving Self-Care of Patients With Heart Failure
NCT00645489
Enhancing Heart Failure Self-Care
NCT00526773
Effectiveness of Peer Support in Improving Heart Failure Self-Management and Care
NCT00508508
Therapeutic Education Strategy for Patients With Acute Heart Failure
NCT03035123
Patient and Family Partners in Heart Failure Care: Pilot Test of a Pre-visit Question Prompt List to Enhance Engagement During Medical Visits
NCT03491800
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will investigate three ways of giving HF patients and their family members information. The first method is routine HF care; this serves as the control group. The second method adds a patient and family HF education protocol to routine HF care, and the third method adds a Family Partnership Intervention (FPI). The FPI is an experimental procedure that involves discussion and training in ways to improve communication within families. The study takes place over the course of a year. Two hundred sixty two people and their family members will be asked to participate from Emory, Crawford Long, the VA Medical Center and Grady Healthcare System.
Procedures:
All groups will participate in the following activities:
* Complete questionnaires at start of study, then 4 and 8 months afterward (3 times)
* Keep four appointments lasting 1- 4 hours at the General Clinical Research Center (GCRC) located at Emory or Grady Hospital
* Collect 24-hour urine specimens, one at the start of the study, then 4 and 8 months afterward (3 times)
* Keep a 3-day food record, writing down everything you eat and drink, starting two days before each 24-hour urine collection (3 times)
* Use a medication monitoring system attached to the bottle cap of your heart failure medications
* Take a six-minute walk test in which you walk for up to six minutes at the start of study and then 4 and 8 months afterward (3 times)
* Provide blood samples for Brain Natriuretic Peptide (BNP) levels to determine the level of heart failure present at the start of the study and then 4 and 8 months afterward (3 times)
In addition to the above activities, you will be assigned to one of three groups by a computer program. There is a one in three chance of being in any given group.
First Method: The first group will receive routine HF care in addition to participating in the activities listed above.
Second Method: The second group will attend two HF education classes with their family member and with a registered nurse and dietician in addition to routine HF care and participating in the activities listed above. An educational HF newsletter will be sent and subjects will receive two telephone calls by an RN at two weeks and five months after start of the study (1 time for newsletter and two phone calls).
Third Method: The third group will attend patient and family HF education classes and support group meetings with their family member in addition to routine HF care and participating in the activities listed above. An educational HF newsletter with additional information about building Family Partnerships will be sent and an RN will call at two weeks and five months after start of the study (1 time for newsletter and two phone calls).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care Attention Control
Usual care with provision of supplemental printed educational material on HF self care
Usual care with educational material
Usual care with provision of printed educational material, provided once at baseline
Group 2 Patient Family Education PFE
Patient Family Education PFE Heart Failure Patients and family member dyads were provided with an educational and counseling session, and attended a 2 hour patient-family education session on heart failure self management with emphasis on dietary sodium and medication taking behaviors.
Patient and Family Education
HF Patient and one family member receive structured education sessions one month after enrollment.Two sessions, one indivdual with patient-family member dyad after baseline, and one in a group setting between 2-3 months after baseline. The group session was 2 hours in duration. Telephone counseling for the dyad ast 5-6 months, mailed newsletters at Mailed newsletters at 5-6 months.
Usual care with educational material
Usual care with provision of printed educational material, provided once at baseline
Group 3 Family Partnership Intervention
Patient and family member received one individual dyadic education/counseling session, and two group sessions focused on developing family approaches to HF self management. the emphasis of the two group sessions was on developing autonomy supportive approaches to family support.
Family Partnership Intervention (FPI)
HF patient and family receive structured patient and family education sessions plus intervention to improve family communication one month after enrollment.Patient and family member received one individual dyadic education/counseling session after baseline data collection, and two group sessions (2-3 months after baseline) focused on developing family approaches to HF self management.Telephone counseling for the dyad and reinforcing mailed newsletters at 5-6 months after baseline.
Patient and Family Education
HF Patient and one family member receive structured education sessions one month after enrollment.Two sessions, one indivdual with patient-family member dyad after baseline, and one in a group setting between 2-3 months after baseline. The group session was 2 hours in duration. Telephone counseling for the dyad ast 5-6 months, mailed newsletters at Mailed newsletters at 5-6 months.
Usual care with educational material
Usual care with provision of printed educational material, provided once at baseline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Family Partnership Intervention (FPI)
HF patient and family receive structured patient and family education sessions plus intervention to improve family communication one month after enrollment.Patient and family member received one individual dyadic education/counseling session after baseline data collection, and two group sessions (2-3 months after baseline) focused on developing family approaches to HF self management.Telephone counseling for the dyad and reinforcing mailed newsletters at 5-6 months after baseline.
Patient and Family Education
HF Patient and one family member receive structured education sessions one month after enrollment.Two sessions, one indivdual with patient-family member dyad after baseline, and one in a group setting between 2-3 months after baseline. The group session was 2 hours in duration. Telephone counseling for the dyad ast 5-6 months, mailed newsletters at Mailed newsletters at 5-6 months.
Usual care with educational material
Usual care with provision of printed educational material, provided once at baseline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 21-79
* Currently taking angiotensin-converting enzyme (ACE) inhibitor and diuretic medications
* Recommended to exercise and low sodium diet
* Willing to participate in educational sessions with a family member
* Willing to spend a minimum of 9 hours and a maximum of 15 hours over an 8-month period
* Willing to travel to either Emory University Hospital or Grady Memorial Hospital General Clinical Research Center (GCRC) for study activities
Exclusion Criteria
* Heart attack within the last 6 months
* Kidney failure
* Significant angina/chest pain
* Inability to read and write English
21 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Nursing Research (NINR)
NIH
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandra B. Dunbar, RN
Professor, Emory University, Nell Hodgson Woodruff School of Nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sandra B. Dunbar, RN, DSN
Role: PRINCIPAL_INVESTIGATOR
Emory University School of Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Grady Hospital
Atlanta, Georgia, United States
Crawford Long Hospital
Atlanta, Georgia, United States
Emory University Hospital
Atlanta, Georgia, United States
Atlanta Veterans Affairs (VA) Medical Center
Decatur, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.